Compare VMET & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VMET | AMPH |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.7M | 885.4M |
| IPO Year | 2025 | 2005 |
| Metric | VMET | AMPH |
|---|---|---|
| Price | $10.10 | $20.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $28.38 |
| AVG Volume (30 Days) | 184.5K | ★ 442.0K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $185.47 | $6.90 |
| Revenue Next Year | $16.05 | $4.64 |
| P/E Ratio | ★ N/A | $24.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.48 | $16.65 |
| 52 Week High | $13.81 | $31.26 |
| Indicator | VMET | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 52.36 |
| Support Level | $8.53 | $18.36 |
| Resistance Level | $13.56 | $20.29 |
| Average True Range (ATR) | 0.45 | 0.77 |
| MACD | 0.20 | 0.03 |
| Stochastic Oscillator | 96.35 | 33.11 |
Versamet Royalties Corp is a diversified metals royalty and streaming company with exposure to a range of resource royalties and streams including gold, silver, copper, zinc, graphite and uranium, across a variety of jurisdictions. The Company's operating segments are considered to be its individual royalties, streams and the Greenstone gold interest.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.